Galmed Pharmaceuticals Ltd. Files SEC Form SC 13G/A, Statement of Beneficial Ownership By Certain Investors: (Sept. 20, 2024).
Předmět: | |
---|---|
Zdroj: | Pharma Business Week; 10/10/2024, p1625-1625, 1p |
Abstrakt: | Galmed Pharmaceuticals Ltd., a biopharmaceutical company, has filed a Form SC 13G/A with the U.S. Securities and Exchange Commission (SEC). The filing, made on September 20, 2024, is a formal document or financial statement submitted by publicly-traded companies. The contact information for Galmed Pharmaceuticals Ltd. is provided in the filing. For more information on the filing, readers can visit the SEC's website. [Extracted from the article] |
Databáze: | Complementary Index |
Externí odkaz: |